Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/22/2012WO2012156382A1 Novel crystalline asenapine hydrochloride salt forms
11/22/2012WO2012156380A1 Method for treatment of advanced solid tumors
11/22/2012WO2012156367A1 Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
11/22/2012WO2012156351A1 Epha4 is a disease modifier in motor neuron disease
11/22/2012WO2012156339A1 New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
11/22/2012WO2012156334A1 Inhibitors of bruton's tyrosine kinase
11/22/2012WO2012156317A2 Intranasal pharmaceutical dosage forms comprising naloxone
11/22/2012WO2012156312A1 Pharmaceutical combination for use in the treatment of diabetes type 2
11/22/2012WO2012156311A1 Use of cathepsin k inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure
11/22/2012WO2012156299A1 Lixisenatide as add-on therapy to basal insulin in type 2 diabetes
11/22/2012WO2012156298A1 Lixisenatide and metformin for treatment of diabetes type 2
11/22/2012WO2012156296A1 Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients
11/22/2012WO2012156289A1 Pharmaceutical compositions comprising neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers
11/22/2012WO2012156284A1 1,3-oxazines as bace1 and/or bace2 inhibitors
11/22/2012WO2012156283A1 Method for treatment of solid malignancies including advanced or metastatic solid malignancies
11/22/2012WO2012156275A1 Compositions containing resveratrol and essential oil of cloves for the treatment of itching
11/22/2012WO2012156225A1 Use of a sulfurated compound for the treatment of hyper-homocysteinemia.
11/22/2012WO2012155981A1 New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby
11/22/2012WO2012155834A1 Preparation method for rivastigmine, intermediates thereof, and preparation method for said intermediates
11/22/2012WO2012155827A1 Use of indole-2,3-dione in preparing medicine for improving dyszoospermia
11/22/2012WO2012155824A1 Ancomycin and its derivatives, preparation methods and uses thereof
11/22/2012WO2012155806A1 4-aminoquinazoline derivatives and uses thereof
11/22/2012WO2012155559A1 Organic hybridized tetra-core platinum complex and preparation method thereof as well as the use thereof in manufacturing medicament for antitumor
11/22/2012WO2012155339A1 4-phenylamino-6-butenamide-7-alkyloxy quinazoline derivatives, preparative method and use thereof
11/22/2012WO2012155226A1 Method for producing pyrostegia venusta derivatives, pyrostegia venusta derivatives, pharmaceutical compositions and uses thereof
11/22/2012WO2012155203A1 Regulation of nitric oxide release and biofilm development
11/22/2012WO2012155199A1 Amine derivatives as potassium channel blockers
11/22/2012WO2012155172A1 Method of treatment or prophylaxis of bacterial vaginosis
11/22/2012WO2012142237A8 Fused imidazole derivatives useful as ido inhibitors
11/22/2012WO2012139001A3 Kinase protein binding inhibitors
11/22/2012WO2012135868A3 Compositions and methods for the treatment and prevention of cardiac ischemic injury
11/22/2012WO2012135632A3 Methods of treating a subject having been exposed to a catastrophic event
11/22/2012WO2012135619A3 Intranasal benzodiazepine pharmaceutical compositions
11/22/2012WO2012135600A3 Gall wasp control agents
11/22/2012WO2012135149A9 Small molecule modulators of sirt1 activity activate p53 and suppress tumor growth
11/22/2012WO2012135112A3 Methods for preparing deuterated 1,2,3-triazoles
11/22/2012WO2012135016A3 Inhibition of bacterial biofilms and microbial growth with imidazole derivatives
11/22/2012WO2012135010A3 Osmotic mediated release synthetic nanocarriers
11/22/2012WO2012134172A3 Composition containing, as an active ingredient, an ethyl acetate fraction of schisandra chinensis baill, or wuweizisu c separated from the fraction, for preventing or treating obesity
11/22/2012WO2012131656A3 Compounds for use as therapeutic agents affecting p53 expression and/or activity
11/22/2012WO2012126178A3 Pharmaceutical composition for treating hepatic disease
11/22/2012WO2012119938A3 Use of aptamers in therapy and/or diagnosis of autoimmune diseases
11/22/2012WO2012118915A3 Compositions and methods for treatment of tamoxifen resistant breast cancer
11/22/2012WO2012116196A3 Substituted lactosyl compounds and use thereof for cellular imaging and therapy
11/22/2012WO2012112956A3 Compounds and methods for targeting leukemic stem cells
11/22/2012WO2012112796A3 Perfluoro(n-butylcyclohexane) compositions and uses thereof
11/22/2012WO2012109605A8 Forms of rifaximin and uses thereof
11/22/2012WO2012100229A3 Compositions and methods for cardiovascular disease
11/22/2012WO2012100228A3 Methods and compositions for treating kidney disorders
11/22/2012WO2012098560A3 Process for the preparation of muscarinic receptor antagonist
11/22/2012WO2012096718A3 Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers, and liver health maintenance
11/22/2012WO2012096494A3 Agent containing b-ring-substituted flavonoid derivatives for treating arthritis
11/22/2012WO2012092288A3 Compositions and methods of using crystalline forms of wortmannin analogs
11/22/2012WO2012090124A3 IN SITU GENERATION OF PEROXYCARBOXYLIC ACIDS AT ALKALINE pH, AND METHODS OF USE THEREOF
11/22/2012WO2012088382A3 Amyris alcohol and its ester for treating acne
11/22/2012WO2012085656A3 Encased tamper resistant controlled release dosage forms
11/22/2012WO2012068169A3 Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
11/22/2012WO2012065057A3 Phosphatidylinositol 3-kinase inhibitors and methods of their use
11/22/2012WO2012051107A8 Niacin formulations and methods with reduced flushing side-effect
11/22/2012WO2012037008A3 Therapy for mll-rearranged leukemia
11/22/2012WO2011124895A3 Phospholipid-containing pharmaceutical and nutraceutical compositions
11/22/2012WO2011093742A8 Agent for treating parkinson's disease
11/22/2012US20120297495 Zinc-finger nuclease and rna interference mediated inactivation of viral genomes
11/22/2012US20120296403 Methods and compounds for muscle growth
11/22/2012US20120296274 Delivery of coated hydrophobic active agent particles
11/22/2012US20120296263 Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris
11/22/2012US20120296088 Synthesis of udp-glucose: n-acylsphingosine glucosyl transferase inhibitors
11/22/2012US20120296084 Carbapenem Antibacterials with Gram-Negative Activity and Processes for Their Preparation
11/22/2012US20120296081 Carrageenan Based Antimicrobial Compositions
11/22/2012US20120296080 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
11/22/2012US20120296072 N-terminally chemically modified protein compositions and methods
11/22/2012US20120295988 Pharmaceutical Compositions of Dispersions of Amorphous Drugs Mixed with Polymers
11/22/2012US20120295985 Methods for improving blood glucose control
11/22/2012US20120295983 Stabilized Cationic Ammonium Compounds for Topical Compositions
11/22/2012US20120295982 Treating human male copd patients with oral bedoradrine
11/22/2012US20120295981 Tetrasubstituted benzenes
11/22/2012US20120295980 Compounds and methods for delivery of prostacyclin analogs
11/22/2012US20120295979 Use of sulindac for protecting retinal pigment epithelial cells against oxidative stress
11/22/2012US20120295978 Diclofenac gel
11/22/2012US20120295977 Organosulfur prodrugs for the prevention and treatment of infectious diseases
11/22/2012US20120295976 Composition and/or method for preventing recurrence of stroke
11/22/2012US20120295975 Methods of treating inflammatory conditions
11/22/2012US20120295974 Trans-, trans-conjugated linoleic acid compositions and use thereof
11/22/2012US20120295973 Methods and compositions of derivatives of probucol for the treatment of diabetes
11/22/2012US20120295971 Therapeutic compositions
11/22/2012US20120295970 Therapeutic compositions
11/22/2012US20120295969 Novel Muscle Relaxant Using Negatively Charged Gold with Choline
11/22/2012US20120295968 Pharmaceutical Composition Comprising Cannabinoids
11/22/2012US20120295967 High concentration olopatadine ophthalmic composition
11/22/2012US20120295966 Chromone Inhibitors of S-Nitrosoglutathione Reductase
11/22/2012US20120295965 Fused thiophenes as dual inhibitors of egfr/vegfr and their use in the treatment of cancer
11/22/2012US20120295963 Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial
11/22/2012US20120295962 Targeting micrornas for the treatment of liver cancer
11/22/2012US20120295961 Modulation of hepatitis b virus (hbv) expression
11/22/2012US20120295959 Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1
11/22/2012US20120295958 Modulation of glucagon receptor expression
11/22/2012US20120295957 Prevention of tissue ischemia and related compositions
11/22/2012US20120295956 Prevention of tissue ischemia and related methods
11/22/2012US20120295955 Rna antagonist compounds for the modulation of her3
11/22/2012US20120295954 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
1 ... 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 ... 7860